The main objective of this study is to identify and characterize subpopulations of cells with invasive capacity in colorectal cancer from primary tumor, blood and metastatic samples.
Secondary objectives include: * Determine the intrinsic properties essential for the dissemination and chemoresistance of these cells capable of initiating tumors * Identify a "molecular signature" for potential invasiveness and chemoresistance of cells initiating metastases. * Describe the evolution of patients during 24 months of follow up and correlations with observed cellular profiles. * Enrich the tumor bank of the institution.
Study Type
OBSERVATIONAL
Enrollment
60
Samples: Peroperative blood sample plus primary and metastatic tumor biopsies. Follow-up: disease outcomes assessed at 24 months
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, Gard, France
Ability to maintain the cells isolated from colorectal tumors in culture or 3D collagen matrices and then infect these cells to make them express reporter genes: yes/no.
Time frame: Baseline (Day 0)
Serology HIV
Time frame: baseline; day 0
Serology Hepatitis B
Time frame: baseline; day 0
Serology Hepatitis C
Time frame: baseline; day 0
Location of primary tumor
right colon, left colon, transverse colon, sigmoid, rectum
Time frame: base line; day 0
Age at diagnosis
Time frame: baseline, day 0
Metastases from the outset: Yes / No
Time frame: baseline, day 0
Resection proposed: yes/no
Time frame: baseline, day 0
Chemotherapy proposed? yes/no
Time frame: baseline, day 0
Number of metastases
Time frame: 24 months
Resection performed: yes/no
Time frame: 24 months
Number of chemotherapy sessions performed
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 24 months
Objective tumoral response to treatment? yes/no
Time frame: 24 months
Tumor recurrence: yes/no
Time frame: 24 months
Vital status
living/deceased
Time frame: 24 months
Ability to establish tumor xenografts from injected cells: yes/no.
Time frame: baseline; Day 0
Ability to detect subpopulations of tumor cells expressing fluorophores by flow cytometry after isolation: yes/no
Time frame: baseline; day 0
Characterization of mRNA expression profiling and micro-RNA + in vitro EMT cells
Time frame: baseline; day 0
World Health Organisation Score
Time frame: 24 months
Tumor staging
Time frame: 24 months
Number of surgeries performed
Time frame: 24 months
Number of circulating cancer cells per ml blood
Time frame: baseline; day 0